Bambusa Therapeutics
PrivateLast Round
Series A
Feb 14, 2025
Total Funding Raised
$105M
Momentum Score
75 /100
Company Overview
Bambusa Therapeutics is a biotechnology company that develops bispecific antibodies for the treatment of immunological and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bambusa Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Bambusa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 14, 2025 | ||||
| Seed | Sep 9, 2024 | ||||
| Series A Extension | Nov 17, 2023 |
Bambusa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series A, Series A Extension |
| Salvia | Series A |
| Janus Henderson Group | Series A, Series A Extension |
| ADAR1 Capital Management | Series A |
| RA Capital Management | Series A Extension, Series A |
| Kohlberg Kravis Roberts | Series A |
| 渶策资本 | Series A, Series A Extension, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 18% QoQ from 17 to 20 employees.
- Apr 25, 2026
Grew 36% QoQ, from 14 to 19 employees.
Bambusa Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bambusa Therapeutics's valuation, stock price, and market status.
